This month, the US Supreme Court will hear arguments in the case of a woman who suffered the gruesome skin reaction toxic epidermal necrosis (TEN) after taking a generic form of sulindac, a mild non-steroidal … Read more…
I love a good deal but there are certain things that just aren’t worth the savings when considering the option of buying used goods. Here are a few products that you should always buy new.
The U.S. Centers for Disease Control and Prevention found detectable levels of BPA in the urine of 93 percent of Americans over the age of six; and yet, there remain no national regulations designed to prevent BPA from contaminating food.
Since 2010, Johnson & Johnson has issued more than 50 voluntary product recalls, one of the latest of which is for the DePuy replacement hip.
This article explores the link between Crestor and two potentially fatal side effects, cardiomyopathy and rhabdomyolysis. Crestor (rosuvastatin calcium) has not been recalled as of the date of this writing.
A great concern facing the public now is the failure of metal-on-metal hip arthroplasties using systems like the recently recalled DePuy ASR. This is a guest article submitted by Jim Moreland PA-C, MHS and does not necessarily represent the views of this website.
The hip implant study by these two doctors showed that short and medium term clinical outcomes show third-generation alumina ceramic have shown low incidence of osteolysis, wear and failures.
So we have an open question for Toyota: Is it the all-weather floor mat accessory, the gas pedal length, mechanical friction in the accelerator assembly, or an electrical problem? Or are these all separate issues?
We’ve asked Joel Salatin a few questions about our nation’s food supply – especially in regard to food safety – and would like to share his responses with you.
We offer several ways for you to stay updated on recalls, including our recall alerts by email. Now you can also follow US Recall News on Twitter or Facebook for even faster updates and alerts!
In February 2009, the FDA announced that they would begin the process to require Risk Evaluation and Mitigation Strategies (REMS) to help curtail the misuse of the drugs referred to as opioid pain products.